Ultragenyx Pharmaceutical Inc. Insider Trading for August 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ultragenyx Pharmaceutical Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ultragenyx Pharmaceutical Inc. for August 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 25 2020 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Option Exercise | M | 58.74 | 5,000 | 293,700 | 0 | |
Aug 25 2020 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Sell | S | 86.57 | 5,000 | 432,850 | 57,018 | 62 K to 57 K (-8.06 %) |
Aug 25 2020 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Buy | M | 58.74 | 5,000 | 293,700 | 62,018 | 57 K to 62 K (+8.77 %) |
Aug 19 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Option Exercise | M | 54.50 | 10,000 | 545,000 | 45,000 | |
Aug 19 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Sell | S | 88.39 | 2,370 | 209,484 | 24,293 | 26.7 K to 24.3 K (-8.89 %) |
Aug 19 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Sell | S | 88.44 | 10,000 | 884,400 | 26,663 | 36.7 K to 26.7 K (-27.28 %) |
Aug 19 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Buy | M | 54.50 | 10,000 | 545,000 | 36,663 | 26.7 K to 36.7 K (+37.51 %) |
Aug 19 2020 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Option Exercise | M | 48.43 | 3,669 | 177,690 | 15,312 | |
Aug 19 2020 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Option Exercise | M | 67.55 | 7,188 | 485,549 | 15,812 | |
Aug 19 2020 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Option Exercise | M | 70.57 | 500 | 35,285 | 0 | |
Aug 19 2020 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Sell | S | 88.38 | 3,669 | 324,266 | 98,187 | 101.9 K to 98.2 K (-3.60 %) |
Aug 19 2020 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Buy | M | 48.43 | 3,669 | 177,690 | 101,856 | 98.2 K to 101.9 K (+3.74 %) |
Aug 19 2020 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Sell | S | 88.38 | 7,188 | 635,275 | 98,187 | 105.4 K to 98.2 K (-6.82 %) |
Aug 19 2020 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Buy | M | 67.55 | 7,188 | 485,549 | 105,375 | 98.2 K to 105.4 K (+7.32 %) |
Aug 19 2020 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Sell | S | 88.38 | 500 | 44,190 | 98,187 | 98.7 K to 98.2 K (-0.51 %) |
Aug 19 2020 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Buy | M | 70.57 | 500 | 35,285 | 98,687 | 98.2 K to 98.7 K (+0.51 %) |
Aug 19 2020 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Sell | S | 88.54 | 2,560 | 226,662 | 98,187 | 100.7 K to 98.2 K (-2.54 %) |
Aug 19 2020 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Sell | S | 88.24 | 461 | 40,679 | 100,747 | 101.2 K to 100.7 K (-0.46 %) |
Aug 11 2020 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Director | Option Exercise | M | 40.37 | 1,596 | 64,431 | 0 | |
Aug 11 2020 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Director | Option Exercise | M | 21.00 | 17,500 | 367,500 | 0 | |
Aug 11 2020 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Director | Option Exercise | M | 40.37 | 5,904 | 238,344 | 1,596 | |
Aug 11 2020 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Director | Sell | S | 85.01 | 1,596 | 135,676 | 2,550 | 4.1 K to 2.6 K (-38.49 %) |
Aug 11 2020 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Director | Buy | M | 40.37 | 1,596 | 64,431 | 4,146 | 2.6 K to 4.1 K (+62.59 %) |
Aug 11 2020 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Director | Sell | S | 85.01 | 9,750 | 828,848 | 2,550 | 12.3 K to 2.6 K (-79.27 %) |
Aug 11 2020 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Director | Sell | S | 85.55 | 23,404 | 2,002,212 | 12,300 | 35.7 K to 12.3 K (-65.55 %) |
Aug 11 2020 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Director | Buy | M | 21.00 | 17,500 | 367,500 | 35,704 | 18.2 K to 35.7 K (+96.13 %) |
Aug 11 2020 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Director | Buy | M | 40.37 | 5,904 | 238,344 | 18,204 | 12.3 K to 18.2 K (+48.00 %) |